WDR5 and central nervous system cancer: In human glioma, PRMT5 facilitates the enrichment of H3R2me1 and H3R2me2s, recruiting WD repeat domain 5 (WDR5) to promote H3K4 methylation at the VEGFA promoter, thereby enhancing its transcription [51].